The full content of Annals is available to subscribers

Subscribe/Learn More  >
Original Research |

Reflux Esophagitis: Effect of Oral Bethanechol on Symptoms and Endoscopic Findings

[+] Article, Author, and Disclosure Information

Grant support: in part by The Genesee Hospital Gastrointestinal Research Fund.

This work was presented in part at the 79th Annual Meeting of the American Gastroenterological Association, Las Vegas, Nevada, 1978, and was published in abstract form in Gastroenterology. 1978;74:1147.

▸Requests for reprints should be addressed to Krishan D. Thanik, M.D.; The Isaac Gordon Center for Digestive Diseases and Nutrition, Department of Medicine, The Genesee Hospital, 224 Alexander Street; Rochester, NY 14607.

Rochester, New York

Ann Intern Med. 1980;93(6):805-808. doi:10.7326/0003-4819-93-6-805
Text Size: A A A

We ascertained the effectiveness of oral bethanechol on symptoms and endoscopic evaluation of reflux esophagitis in a double-blind controlled study. Forty-four patients were treated with either 25-mg bethanechol tablets or placebo, each given four times daily for 4 weeks, in addition to conventional medical therapy. Both therapies significantly decreased symptoms as well as endoscopic lesions; however, endoscopic improvement was significantly better in the bethanechol-treated group. Bethanechol therapy resulted in complete endoscopic healing in 10 of 22 cases, whereas only three of 22 patients in the control group had such healing. No worsening of endoscopic lesions was seen in either group. Our study indicates that bethanechol is an effective drug offering advantages over conventional antacid therapy in the treatment of reflux esophagitis.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $42.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
Current management of gastroesophageal reflux disease. Gastroenterologist 1996;4(1):24-32.
Pharmacologic modulation of motility. Yale J Biol Med ;72(2-3):173-80.
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.